[225Ac]-FPI-2068

· AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [225Ac]-FPI-2068, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]